Download presentation
Presentation is loading. Please wait.
1
A Primer on Opioids/Opiates
Richard L. Bell, Ph.D. Associate Professor Department of Psychiatry Indiana University School of Medicine ***Earlier in the literature “opiates” referred to exogenous ligands for opioid receptors, whereas “opioids” referred to endogenous ligands for opioid receptors
3
Opioid Agonists Exogenous opioids Endogenous opioids
Mu agonist (Ag) morphine, fentanyl, methadone, codeine, hydrocodone, oxycodone, hydromorphone, levorphanol, meperidine, oxymorphone, tramadol, propoxyphene, sufentanil, remifentanil Mu pAg pentazocine, butorphanol, nalbuphine, buprenorphine Delta receptor morphine, fentanyl Kappa receptor morphine, fentanyl, pentazocine, butorphanol, nalbuphine Naloxone mu, delta, and kappa antagonist Naltrexone mu, delta, and kappa antagonist Endogenous opioids Mu receptor beta-endorphin, endomorphin Delta receptor leu-encephalin, met-encephalin, beta-endorphin Kappa receptor dynorphin
5
Befort 2015 Front Pharmacol
6
Delta receptor location and emotional/cognitive/physiological function
Chung and Kieffer 2013 Pharmacol Ther
7
Mu- and delta-receptor co-expression and functional areas of the brain (red reflects only mu-receptor) Erbs et al 2015 Brain Struct Funct
8
Lalanne et al 2014 Front Psychiatry
9
Yijun-Cui et al 2014 Nature Neuroscience
10
Navratilova and Porreca 2014 Nature Neuroscience
11
Opioid Treatments for Addiction
12
Transcranial Stimulation decreases mu-opioid receptor
binding.
13
National Institute on Drug Abuse; Center for Disease Control and Prevention
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.